{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:47:05Z","timestamp":1794336425486,"version":"4.9.0"},"reference-count":290,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.neurol.2022.12.006","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T08:01:28Z","timestamp":1678348888000},"page":"812-830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology"],"prefix":"10.1016","volume":"179","author":[{"given":"D.","family":"Gouilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1501-9113","authenticated-orcid":false,"given":"M.","family":"Rafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-S.","family":"Salabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Payoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7200-0139","authenticated-orcid":false,"given":"P.","family":"P\u00e9ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5580","key":"10.1016\/j.neurol.2022.12.006_bib1000","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrneurol.2013.21","article-title":"A\u03b2-independent processes\u2014rethinking preclinical AD","volume":"9","author":"Ch\u00e9telat","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib1015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00401-015-1390-7","article-title":"PART is part of Alzheimer disease","volume":"129","author":"Duyckaerts","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1020","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat Genet"},{"issue":"10248","key":"10.1016\/j.neurol.2022.12.006_bib1025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41583-018-0113-1","article-title":"Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis","volume":"20","author":"Henstridge","year":"2019","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"0","key":"10.1016\/j.neurol.2022.12.006_bib1040","article-title":"Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group","volume":"0","author":"Dubois","year":"2021","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1045","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's Dementia"},{"issue":"9","key":"10.1016\/j.neurol.2022.12.006_bib1050","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMp058027","article-title":"Genetic factors in Alzheimer's disease","volume":"352","author":"Bird","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","article-title":"The probabilistic model of Alzheimer disease: the amyloid hypothesis revised","volume":"23","author":"Frisoni","year":"2022","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"13","key":"10.1016\/j.neurol.2022.12.006_bib1065","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib1070","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer's disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat Neurosci"},{"issue":"8","key":"10.1016\/j.neurol.2022.12.006_bib1075","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nn0805-977","article-title":"The synaptic A\u03b2 hypothesis of Alzheimer disease","volume":"8","author":"Tanzi","year":"2005","journal-title":"Nat Neurosci"},{"issue":"5054","key":"10.1016\/j.neurol.2022.12.006_bib1080","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study","volume":"17","author":"Gordon","year":"2018","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1016\/j.neurol.2022.12.006_bib1095","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","article-title":"New insights into atypical Alzheimer's disease in the era of biomarkers","volume":"20","author":"Graff-Radford","year":"2021","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2022.12.006_bib1105","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2022.12.006_bib1115","doi-asserted-by":"crossref","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"issue":"19","key":"10.1016\/j.neurol.2022.12.006_bib1120","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.neurol.2022.12.006_bib1125","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.2015.4669","article-title":"Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis","volume":"313","author":"Ossenkoppele","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/NEN.0000000000000052","article-title":"Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent \u03b2-amyloid and tau loads with divergent cognitive outcomes","volume":"73","author":"Iacono","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 8","key":"10.1016\/j.neurol.2022.12.006_bib1135","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/brain\/awt171","article-title":"Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology","volume":"136","author":"Perez-Nievas","year":"2013","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib1140","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1474-4422(16)30125-9","article-title":"Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study","volume":"15","author":"Burnham","year":"2016","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1474-4422(18)30029-2","article-title":"Cognitive and neuroimaging features and brain \u03b2-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study","volume":"17","author":"Dubois","year":"2018","journal-title":"The Lancet Neurology"},{"issue":"8","key":"10.1016\/j.neurol.2022.12.006_bib1150","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jalz.2018.03.005","article-title":"Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease","volume":"14","author":"Brookmeyer","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"22","key":"10.1016\/j.neurol.2022.12.006_bib1155","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2017.6669","article-title":"Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons","volume":"317","author":"Donohue","year":"2017","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.neurol.2022.12.006_bib1160","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0000000000004627","article-title":"Subjective cognitive decline and \u03b2-amyloid burden predict cognitive change in healthy elderly","volume":"89","author":"Vogel","year":"2017","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.neurol.2022.12.006_bib1165","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1212\/WNL.0b013e31828ab35d","article-title":"Meta-analysis of amyloid-cognition relations in cognitively normal older adults","volume":"80","author":"Hedden","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamapsychiatry.2017.3391","article-title":"Association of cerebral amyloid-\u03b2 aggregation with cognitive functioning in persons without dementia","volume":"75","author":"Jansen","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"23","key":"10.1016\/j.neurol.2022.12.006_bib1175","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1001\/jama.2019.7437","article-title":"Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia","volume":"321","author":"Jack","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1180","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009724","article-title":"ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project","volume":"95","author":"Ebenau","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13195-018-0459-7","article-title":"Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis","volume":"11","author":"Parnetti","year":"2019","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.25395","article-title":"The impact of amyloid-beta and tau on prospective cognitive decline in older individuals","volume":"85","author":"Sperling","year":"2019","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2022.12.006_bib1195","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jalz.2019.05.006","article-title":"Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study","volume":"15","author":"Yu","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"20","key":"10.1016\/j.neurol.2022.12.006_bib1200","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/WNL.0000000000000431","article-title":"Amyloid and APOE \u025b4 interact to influence short-term decline in preclinical Alzheimer disease","volume":"82","author":"Mormino","year":"2014","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib1205","first-page":"830","article-title":"Association of longitudinal cognitive decline with amyloid burden in middle-aged and older adults: evidence for a dose-response relationship. JAMA Neurol","volume":"74","author":"Farrell","year":"2017"},{"issue":"9","key":"10.1016\/j.neurol.2022.12.006_bib1210","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jalz.2018.07.219","article-title":"Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance","volume":"16","author":"Stern","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.neurol.2022.12.006_bib1215","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41583-018-0068-2","article-title":"Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing","volume":"19","author":"Cabeza","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41582-018-0008-9","article-title":"Amyloid-\u03b2 \u2014 a reflection of risk or a preclinical marker?","volume":"14","author":"Jack","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1230","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jnen\/nlw002","article-title":"Altered proteins in the aging brain","volume":"75","author":"Elobeid","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1235","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib1240","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00401-021-02294-3","article-title":"Cryo-EM structures of tau filaments from Alzheimer's disease with PET ligand APN-1607","volume":"141","author":"Shi","year":"2021","journal-title":"Acta Neuropathol"},{"issue":"7880","key":"10.1016\/j.neurol.2022.12.006_bib1245","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","article-title":"Structure-based classification of tauopathies","volume":"598","author":"Shi","year":"2021","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib1250","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1093\/brain\/awaa248","article-title":"Predicting future rates of tau accumulation on PET","volume":"143","author":"Jack","year":"2020","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1255","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ana.24910","article-title":"Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline","volume":"81","author":"Hanseeuw","year":"2017","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib1260","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.0000000000009058","article-title":"Biological subtypes of Alzheimer disease: a systematic review and meta-analysis","volume":"94","author":"Ferreira","year":"2020","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurol.2022.12.006_bib1265","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study","volume":"10","author":"Murray","year":"2011","journal-title":"The Lancet Neurology"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib1270","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1474-4422(12)70200-4","article-title":"Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study","volume":"11","author":"Whitwell","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2022.12.006_bib1275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2018.01.009","article-title":"Heterogeneous patterns of brain atrophy in Alzheimer's disease","volume":"65","author":"Poulakis","year":"2018","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1280","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/01.WNL.0000110315.26026.EF","article-title":"Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD","volume":"62","author":"Jack","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib1285","first-page":"548","article-title":"Association between amyloid and tau accumulation in young adults with autosomal dominant Alzheimer Disease. JAMA Neurol","volume":"75","author":"Quiroz","year":"2018"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1290","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/alz.12231","article-title":"Clinical relevance of brain atrophy subtypes categorization in memory clinics","volume":"17","author":"Planche","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1295","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamaneurol.2016.5755","article-title":"Association of In Vivo [18F]AV-1451 Tau PET imaging results with cortical atrophy and symptoms in typical and atypical Alzheimer Disease","volume":"74","author":"Xia","year":"2017","journal-title":"JAMA Neurol"},{"issue":"Pt 5","key":"10.1016\/j.neurol.2022.12.006_bib1300","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib1305","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","article-title":"The Alzheimer's Disease Neuroimaging Initiative et al. Four distinct trajectories of tau deposition identified in Alzheimer's disease","volume":"27","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1310","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00401-010-0794-7","article-title":"Tau pathology in children and young adults: can you still be unconditionally baptist?","volume":"121","author":"Duyckaerts","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease","volume":"17","author":"Arnsten","year":"2021","journal-title":"Alzheimer's Dementia"},{"issue":"11","key":"10.1016\/j.neurol.2022.12.006_bib1320","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41582-018-0070-3","article-title":"Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease","volume":"14","author":"Kivipelto","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"10113","key":"10.1016\/j.neurol.2022.12.006_bib1325","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1330","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneurol.2017.63","article-title":"The changing prevalence and incidence of dementia over time - current evidence","volume":"13","author":"Wu","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"10046","key":"10.1016\/j.neurol.2022.12.006_bib1335","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","article-title":"Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial","volume":"388","author":"Moll van Charante","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib1340","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","article-title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial","volume":"16","author":"Andrieu","year":"2017","journal-title":"The Lancet Neurology"},{"issue":"9984","key":"10.1016\/j.neurol.2022.12.006_bib1345","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1350","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jamaneurol.2017.4365","article-title":"Effect of the Apolipoprotein E genotype on cognitive change during a multidomain lifestyle intervention: a subgroup analysis of a randomized clinical trial","volume":"75","author":"Solomon","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2022.12.006_bib1355","article-title":"Peripheral and central immune system crosstalk in Alzheimer disease \u2014 a research prospectus","author":"Bettcher","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1360","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1365","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1370","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ana.22455","article-title":"Inflammation after trauma: microglial activation and traumatic brain injury","volume":"70","author":"Ramlackhansingh","year":"2011","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1375","first-page":"4","article-title":"Recent advances in the relationship between obesity, inflammation, and insulin resistance","volume":"17","author":"Bastard","year":"2006","journal-title":"Eur Cytokine Netw"},{"issue":"15","key":"10.1016\/j.neurol.2022.12.006_bib1380","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.1000645107","article-title":"Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes","volume":"107","author":"Takeda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1385","article-title":"Anti-Inflammatory Drugs and Risk of Alzheimer's disease: an updated systematic review and meta-analysis","volume":"44","author":"Wang","year":"2015","journal-title":"JAD"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib1390","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2022.12.006_bib1395","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41583-020-0325-z","article-title":"Cellular senescence and Alzheimer disease: the egg and the chicken scenario","volume":"21","author":"Saez-Atienzar","year":"2020","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1400","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12840","article-title":"Tau protein aggregation is associated with cellular senescence in the brain","volume":"17","author":"Musi","year":"2018","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib1405","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","article-title":"Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model","volume":"22","author":"Zhang","year":"2019","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1410","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"issue":"16","key":"10.1016\/j.neurol.2022.12.006_bib1415","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between Apolipoprotein E Genotype and Alzheimer disease: a meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1420","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","article-title":"Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study","volume":"11","author":"Reiman","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1425","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1430","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","article-title":"Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions","volume":"11","author":"Rebeck","year":"1993","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib1435","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1440","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/ana.24369","article-title":"APOE\u025b2 is associated with milder clinical and pathological Alzheimer disease","volume":"77","author":"Serrano-Pozo","year":"2015","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1445","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S1041610209991001","article-title":"Trajectories of cognitive decline in Alzheimer's disease","volume":"22","author":"Wilkosz","year":"2010","journal-title":"Int Psychogeriatr"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib1450","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.279.10.751","article-title":"The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics","volume":"279","author":"Tang","year":"1998","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib1455","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jamaneurol.2020.0414","article-title":"Association of Klotho-VS Heterozygosity with risk of Alzheimer Disease in individuals who carry APOE4","volume":"77","author":"Belloy","year":"2020","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.neurol.2022.12.006_bib1460","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.jalz.2019.05.011","article-title":"Genetic resilience to Alzheimer's disease in APOE \u025b4 homozygotes: A systematic review","volume":"15","author":"Huq","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.neurol.2022.12.006_bib1465","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.neurol.2022.12.006_bib1470","doi-asserted-by":"crossref","first-page":"15163","DOI":"10.1074\/jbc.M114.622209","article-title":"Role of apolipoprotein E in \u03b2-amyloidogenesis: Isoform-specific effects on protofibril to fibril conversion of A\u03b2 in vitro and brain A\u03b2 deposition in vivo","volume":"290","author":"Hori","year":"2015","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1475","doi-asserted-by":"crossref","first-page":"e14586","DOI":"10.1371\/journal.pone.0014586","article-title":"Apolipoprotein E: isoform specific differences in tertiary structure and interaction with amyloid-\u03b2 in human Alzheimer brain","volume":"6","author":"Jones","year":"2011","journal-title":"PLoS One"},{"issue":"49","key":"10.1016\/j.neurol.2022.12.006_bib1480","doi-asserted-by":"crossref","first-page":"19276","DOI":"10.1523\/JNEUROSCI.3487-13.2013","article-title":"Neuronal clearance of amyloid-\u03b2 by endocytic receptor LRP1","volume":"33","author":"Kanekiyo","year":"2013","journal-title":"J Neurosci"},{"issue":"15","key":"10.1016\/j.neurol.2022.12.006_bib1485","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1523\/JNEUROSCI.3442-16.2017","article-title":"Astrocytic LRP1 mediates brain A\u03b2 clearance and impacts amyloid deposition","volume":"37","author":"Liu","year":"2017","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1490","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-018-0286-0","article-title":"Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-\u03b242 by LRP1-dependent apolipoprotein E isoform-specific mechanism","volume":"13","author":"Ma","year":"2018","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1495","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"The Lancet Neurology"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib1500","doi-asserted-by":"crossref","first-page":"e1913909","DOI":"10.1001\/jamanetworkopen.2019.13909","article-title":"Association of apolipoprotein E \u025b4, educational level, and sex with tau deposition and tau-mediated metabolic dysfunction in older adults","volume":"2","author":"Ramanan","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1505","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","article-title":"Association of apolipoprotein E \u025b4 with medial temporal tau independent of amyloid-\u03b2","volume":"77","author":"Therriault","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1510","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","article-title":"APOE \u025b2 is associated with increased tau pathology in primary tauopathy","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.neurol.2022.12.006_bib1515","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"7399","key":"10.1016\/j.neurol.2022.12.006_bib1520","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2022.12.006_bib1525","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","author":"Montagne","year":"2020","journal-title":"Nature, 581(7806(7806, May"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1530","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-014-1340-9","article-title":"A\u03b2 immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy","volume":"128","author":"Sakai","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1535","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","article-title":"Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis","volume":"11","author":"Sperling","year":"2012","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1540","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1545","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneurol.2011.221","article-title":"Autosomal recessive causes likely in early-onset Alzheimer disease","volume":"69","author":"Wingo","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2022.12.006_bib1550","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2016.02.024","article-title":"Assessment of the genetic variance of late-onset Alzheimer's disease","volume":"41","author":"Ridge","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2022.12.006_bib1555","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-385883-2.00008-4","article-title":"The genetics of Alzheimer's Disease","volume":"107","author":"Bertram","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1560","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ng.3766","article-title":"Case-control association mapping by proxy using family history of disease","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2022.12.006_bib1565","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1570","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","article-title":"The multiplex model of the genetics of Alzheimer's disease","volume":"23","author":"Sims","year":"2020","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1575","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(19)30435-1","article-title":"Interpretation of risk loci from genome-wide association studies of Alzheimer's disease","volume":"19","author":"Andrews","year":"2020","journal-title":"The Lancet Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1580","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S1474-4422(19)30435-1","article-title":"Interpretation of risk loci from genome-wide association studies of Alzheimer's disease","volume":"19","author":"Andrews","year":"2020","journal-title":"The Lancet Neurology"},{"issue":"12","key":"10.1016\/j.neurol.2022.12.006_bib1585","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"issue":"Pt 12","key":"10.1016\/j.neurol.2022.12.006_bib1590","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1093\/brain\/awv268","article-title":"Common polygenic variation enhances risk prediction for Alzheimer's disease","volume":"138","author":"Escott-Price","year":"2015","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.neurol.2022.12.006_bib1595","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1474-4422(17)30202-8","article-title":"Genomic profiling and diagnostic biomarkers in Alzheimer's disease","volume":"16","author":"Escott-Price","year":"2017","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1600","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3233\/JAD-170834","article-title":"Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline","volume":"62","author":"Del-Aguila","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"10.1016\/j.neurol.2022.12.006_bib1605","first-page":"1373","article-title":"Rare coding variants in PLCG2","volume":"49","author":"ARUK Consortium et al.","year":"2017","journal-title":"ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet"},{"issue":"9","key":"10.1016\/j.neurol.2022.12.006_bib1610","first-page":"1373","article-title":"Rare coding variants in PLCG2","volume":"49","author":"Sims","year":"2017","journal-title":"ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet"},{"issue":"8","key":"10.1016\/j.neurol.2022.12.006_bib1615","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41380-018-0112-7","article-title":"Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation","volume":"25","author":"Bis","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1620","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00401-019-01991-4","article-title":"SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data","volume":"138","author":"Campion","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1625","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3233\/JAD-190193","article-title":"Causative mutations and genetic risk factors in sporadic early onset Alzheimer's disease before 51 years","volume":"71","author":"The collaborators of the CNR-MAJ, et al.","year":"2019","journal-title":"JAD"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1630","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.biopsych.2017.05.014","article-title":"Untangling genetic risk for Alzheimer's Disease","volume":"83","author":"Pimenova","year":"2018","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1635","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jalz.2014.05.1757","article-title":"Convergent genetic and expression data implicate immunity in Alzheimer's disease","volume":"11","author":"International Genomics of Alzheimer's Disease Consortium (IGAP)","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1640","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41398-018-0150-6","article-title":"GWAS on family history of Alzheimer's disease","volume":"8","author":"Marioni","year":"2018","journal-title":"Transl Psychiatry"},{"issue":"7539","key":"10.1016\/j.neurol.2022.12.006_bib1645","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature14252","article-title":"Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease","volume":"518","author":"Gjoneska","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib1650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006933","article-title":"Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease","volume":"13","author":"Lu","year":"2017","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1655","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13073-018-0523-8","article-title":"Genetic risk for Alzheimer's disease is concentrated in specific macrophage and microglial transcriptional networks","volume":"10","author":"Tansey","year":"2018","journal-title":"Genome Med"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1660","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41593-018-0154-9","article-title":"A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease","volume":"21","author":"Mostafavi","year":"2018","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1665","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's Disease","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.neurol.2022.12.006_bib1670","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41582-021-00529-1","article-title":"The human connectome in Alzheimer disease \u2014 relationship to biomarkers and genetics","volume":"17","author":"Yu","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2022.12.006_bib1675","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.dadm.2017.03.007","article-title":"Resting-state network dysfunction in Alzheimer's disease: A systematic review and meta-analysis","volume":"8","author":"Badhwar","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"issue":"8","key":"10.1016\/j.neurol.2022.12.006_bib1680","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0b013e3182a1aafe","article-title":"Impaired default network functional connectivity in autosomal dominant Alzheimer disease","volume":"81","author":"Chhatwal","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1685","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41467-017-01150-x","article-title":"Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity","volume":"8","author":"Palmqvist","year":"2017","journal-title":"Nat Commun"},{"issue":"40","key":"10.1016\/j.neurol.2022.12.006_bib1690","doi-asserted-by":"crossref","first-page":"12686","DOI":"10.1523\/JNEUROSCI.3189-09.2009","article-title":"Disruption of functional connectivity in clinically normal older adults harboring amyloid burden","volume":"29","author":"Hedden","year":"2009","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib1695","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/cercor\/bhr025","article-title":"Relationships between \u03b2-amyloid and functional connectivity in different components of the default mode network in aging","volume":"21","author":"Mormino","year":"2011","journal-title":"Cereb Cortex"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1700","first-page":"695","article-title":"Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability","volume":"26","author":"Elman","year":"2016","journal-title":"Cereb Cortex"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1705","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hbm.23018","article-title":"and Alzheimer's Disease Neuroimaging Initiative, Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks","volume":"37","author":"Grothe","year":"2016","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.neurol.2022.12.006_bib1710","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fnins.2017.00167","article-title":"Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks","volume":"11","author":"Hansson","year":"2017","journal-title":"Front Neurosci"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1715","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/brain\/awx353","article-title":"Networks of tau distribution in Alzheimer's disease","volume":"141","author":"Hoenig","year":"2018","journal-title":"Brain"},{"issue":"23","key":"10.1016\/j.neurol.2022.12.006_bib1720","doi-asserted-by":"crossref","first-page":"19440","DOI":"10.1074\/jbc.M112.346072","article-title":"Trans-cellular propagation of Tau aggregation by fibrillar species","volume":"287","author":"Kfoury","year":"2012","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1725","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41593-018-0070-z","article-title":"Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals","volume":"21","author":"Jacobs","year":"2018","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1730","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuron.2013.01.002","article-title":"Vulnerable neural systems and the borderland of brain aging and neurodegeneration","volume":"77","author":"Jagust","year":"2013","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1735","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2009.03.024","article-title":"Neurodegenerative diseases target large-scale human brain networks","volume":"62","author":"Seeley","year":"2009","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1740","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.neuron.2012.03.004","article-title":"Predicting regional neurodegeneration from the healthy brain functional connectome","volume":"73","author":"Zhou","year":"2012","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1745","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1038\/s41467-019-10217-w","article-title":"A\u03b2-induced vulnerability propagates via the brain's default mode network","volume":"10","author":"Pascoal","year":"2019","journal-title":"Nat Commun"},{"issue":"33","key":"10.1016\/j.neurol.2022.12.006_bib1750","doi-asserted-by":"crossref","first-page":"13642","DOI":"10.1073\/pnas.1303346110","article-title":"Energetic cost of brain functional connectivity","volume":"110","author":"Tomasi","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib1755","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat Neurosci"},{"issue":"12","key":"10.1016\/j.neurol.2022.12.006_bib1760","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1765","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/brain\/awv338","article-title":"Cascading network failure across the Alzheimer's disease spectrum","volume":"139","author":"Jones","year":"2016","journal-title":"Brain"},{"issue":"17","key":"10.1016\/j.neurol.2022.12.006_bib1770","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1073\/pnas.0811879106","article-title":"Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele","volume":"106","author":"Filippini","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.neurol.2022.12.006_bib1775","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archneurol.2011.108","article-title":"Effect of APOE \u025b4 status on intrinsic network connectivity in cognitively normal elderly subjects","volume":"68","author":"Machulda","year":"2011","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib1780","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in Alzheimer's disease","volume":"5","author":"Iadecola","year":"2004","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib1785","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease","volume":"18","author":"Kisler","year":"2017","journal-title":"Nat Rev Neurosci"},{"issue":"12","key":"10.1016\/j.neurol.2022.12.006_bib1790","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1795","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jalz.2018.11.002","article-title":"\u2018Alzheimer's disease\u2019 is neither \u2018Alzheimer's clinical syndrome\u2019 nor \u2018dementia\u2019","volume":"15","author":"Jagust","year":"2019","journal-title":"Alzheimer's Dementia"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1800","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction\u2014The disregarded partner of Alzheimer's disease","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimer's Dementia"},{"issue":"Pt 9","key":"10.1016\/j.neurol.2022.12.006_bib1805","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib1810","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00401-015-1522-0","article-title":"Cerebrovascular disease in ageing and Alzheimer's disease","volume":"131","author":"Love","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1815","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1567205010666131119234845","article-title":"Impaired cerebral autoregulation and vasomotor reactivity in sporadic Alzheimer's disease","volume":"11","author":"den Abeelen","year":"2014","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1820","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archneurol.2009.913","article-title":"APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging","volume":"67","author":"Thambisetty","year":"2010","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1825","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1038\/ncomms11934","article-title":"Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis","volume":"7","author":"The Alzheimer's Disease Neuroimaging Initiative","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1830","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neurobiolaging.2010.02.005","article-title":"Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease","volume":"33","author":"Yezhuvath","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1835","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/bpa.12331","article-title":"Pathophysiology of hypoperfusion of the precuneus in Early Alzheimer's Disease","volume":"26","author":"Miners","year":"2016","journal-title":"Brain Pathol"},{"issue":"Pt 4","key":"10.1016\/j.neurol.2022.12.006_bib1840","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/brain\/awv025","article-title":"Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia","volume":"138","author":"Thomas","year":"2015","journal-title":"Brain"},{"issue":"6450","key":"10.1016\/j.neurol.2022.12.006_bib1845","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.aay2720","article-title":"The vascular side of Alzheimer's disease","volume":"365","author":"Liesz","year":"2019","journal-title":"Science"},{"issue":"6450","key":"10.1016\/j.neurol.2022.12.006_bib1850","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav9518","article-title":"Amyloid \u03b2 oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes","volume":"365","author":"Nortley","year":"2019","journal-title":"Science"},{"issue":"3.","key":"10.1016\/j.neurol.2022.12.006_bib1855","article-title":"Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain","volume":"20","author":"Kisler","year":"2017","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1860","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease \u2014 one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1865","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1870","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.neurol.2022.12.006_bib1875","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib1880","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/brain\/awab099","article-title":"Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease","volume":"144","author":"Spina","year":"2021","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib1885","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/alz.12291","article-title":"Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia","volume":"17","author":"McAleese","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib1890","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology \u2014 concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1895","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1900","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ana.23816","article-title":"Brain injury biomarkers are not dependent on \u03b2-amyloid in normal elderly","volume":"73","author":"Knopman","year":"2013","journal-title":"Annals Neurol"},{"issue":"20","key":"10.1016\/j.neurol.2022.12.006_bib1905","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1212\/WNL.0b013e3182563bbe","article-title":"Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease","volume":"78","author":"Knopman","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1910","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1915","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer's disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.neurol.2022.12.006_bib1920","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.neurobiolaging.2014.06.004","article-title":"Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction","volume":"35","author":"Orre","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1925","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nn.4222","article-title":"Microglial brain region-dependent diversity and selective regional sensitivities to aging","volume":"19","author":"Grabert","year":"2016","journal-title":"Nat Neurosci"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1930","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/bpa.12456","article-title":"Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer's disease","volume":"27","author":"Davies","year":"2017","journal-title":"Brain Pathol"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1935","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00401-018-1902-3","article-title":"Astrocytic degeneration in chronic traumatic encephalopathy","volume":"136","author":"Hsu","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1940","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1038\/cddis.2017.89","article-title":"Aberrant iPSC-derived human astrocytes in Alzheimer's disease","volume":"8","author":"Jones","year":"2017","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib1945","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00401-016-1630-5","article-title":"Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration","volume":"132","author":"Sanchez-Mejias","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1950","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-009-0556-6","article-title":"Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease","volume":"118","author":"Streit","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.1016\/j.neurol.2022.12.006_bib1955","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nm.3639","article-title":"GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease","volume":"20","author":"Jo","year":"2014","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib1960","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","article-title":"The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications","volume":"18","author":"Arranz","year":"2019","journal-title":"The Lancet Neurology"},{"issue":"7784","key":"10.1016\/j.neurol.2022.12.006_bib1965","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1970","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","article-title":"NF\u03baB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease","volume":"85","author":"Lian","year":"2015","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib1975","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jnc.13424","article-title":"Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease","volume":"136","author":"Lian","year":"2016","journal-title":"J Neurochem"},{"issue":"7638","key":"10.1016\/j.neurol.2022.12.006_bib1980","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2022.12.006_bib1985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2013.10.004","article-title":"Neuroinflammation: the role and consequences","volume":"79","author":"Lyman","year":"2014","journal-title":"Neurosci Res"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib1990","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1186\/1742-2094-9-151","article-title":"Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice","volume":"9","author":"Krstic","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"11","key":"10.1016\/j.neurol.2022.12.006_bib1995","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1084\/jem.20190980","article-title":"Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model","volume":"216","author":"Shi","year":"2019","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib2000","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2012.236","article-title":"Deciphering the mechanism underlying late-onset Alzheimer disease","volume":"9","author":"Krstic","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib2005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer's disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib2010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer's disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib2015","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1148-y","article-title":"TREM2 regulates innate immunity in Alzheimer's disease","volume":"15","author":"Li","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurol.2022.12.006_bib2020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fnagi.2018.00395","article-title":"TREM2 in Alzheimer's Disease: microglial survival and energy metabolism","volume":"10","author":"Zheng","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib2025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20160844","article-title":"Soluble TREM2 induces inflammatory responses and enhances microglial survival","volume":"214","author":"Zhong","year":"2017","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib2030","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","article-title":"A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology","volume":"10","author":"Matarin","year":"2015","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib2035","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2019.06.010","article-title":"TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease","volume":"103","author":"Griciuc","year":"2019","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib2040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"issue":"43","key":"10.1016\/j.neurol.2022.12.006_bib2045","doi-asserted-by":"crossref","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","article-title":"Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)","volume":"290","author":"Atagi","year":"2015","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib2050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/alz.12194","article-title":"Functional insights from biophysical study of TREM2 interactions with apoE and A\u03b2 1-42","volume":"17","author":"Kober","year":"2021","journal-title":"Alzheimer's Dementia"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib2055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","article-title":"Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE","volume":"22","author":"Parhizkar","year":"2019","journal-title":"Nat Neurosci"},{"issue":"8","key":"10.1016\/j.neurol.2022.12.006_bib2060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2021.02.010","article-title":"Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology","volume":"109","author":"Lee","year":"2021","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.neurol.2022.12.006_bib2065","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","article-title":"TREM2 function impedes tau seeding in neuritic plaques","volume":"22","author":"Leyns","year":"2019","journal-title":"Nat Neurosci"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib2070","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1474-4422(21)00133-2","article-title":"TREM2-mediated activation of microglia breaks link between amyloid and tau","volume":"20","author":"Hardy","year":"2021","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.neurol.2022.12.006_bib2075","doi-asserted-by":"crossref","DOI":"10.1038\/nature08983","article-title":"Neural mechanisms of ageing and cognitive decline","volume":"464","author":"Bishop","year":"2010","journal-title":"Nature"},{"issue":"7744","key":"10.1016\/j.neurol.2022.12.006_bib2080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","article-title":"Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution","volume":"566","author":"Masuda","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib2085","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2013.12.001","article-title":"The human side of microglia","volume":"37","author":"Smith","year":"2014","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurol.2022.12.006_bib2090","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.15613","article-title":"Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: an update","author":"Gouilly","year":"2022","journal-title":"Eur J Neurosci"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib2095","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00702-017-1731-x","article-title":"In vivo PET imaging of neuroinflammation in Alzheimer's disease","volume":"125","author":"Lagarde","year":"2018","journal-title":"J Neural Transm"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib2100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer's fluid biomarkers","volume":"136","author":"Molinuevo","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurol.2022.12.006_bib2105","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12342","article-title":"Knowledge gaps in Alzheimer's disease immune biomarker research","author":"Morgan","year":"2021","journal-title":"Alzheimer's Dementia"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib2110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/14789450.2017.1304217","article-title":"Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases","volume":"14","author":"Baldacci","year":"2017","journal-title":"Expert Rev Proteomics"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib2115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jalz.2018.12.019","article-title":"Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease","volume":"15","author":"Schindler","year":"2019","journal-title":"Alzheimer's Dementia"},{"issue":"9","key":"10.1016\/j.neurol.2022.12.006_bib2120","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1212\/WNL.0000000000006082","article-title":"CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease","volume":"91","author":"Janelidze","year":"2018","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neurol.2022.12.006_bib2125","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1474-4422(20)30346-X","article-title":"PET imaging of neuroinflammation in neurological disorders","volume":"19","author":"Kreisl","year":"2020","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.neurol.2022.12.006_bib2130","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awy188","article-title":"Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease","author":"Dani","year":"2018","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib2135","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/aww017","article-title":"Early and protective microglial activation in Alzheimer's disease: a prospective study using 18 F-DPA-714 PET imaging","volume":"139","author":"Hamelin","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.12.006_bib2140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neurobiolaging.2016.12.006","article-title":"Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease","volume":"51","author":"Kreisl","year":"2017","journal-title":"Neurobiology of Aging"},{"issue":"9","key":"10.1016\/j.neurol.2022.12.006_bib2145","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1007\/s00415-019-09400-2","article-title":"In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's disease","volume":"266","author":"Terada","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2022.12.006_bib2150","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/aww349","article-title":"An early and late peak in microglial activation in Alzheimer's disease trajectory","author":"Fan","year":"2017","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib2155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12974-020-01820-6","article-title":"The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study","volume":"17","author":"Ismail","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib2160","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/brain\/awy079","article-title":"Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease","volume":"141","author":"Hamelin","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.12.006_bib2165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2019.01.002","article-title":"Neuroinflammation in mild cognitive impairment and Alzheimer's disease: a meta-analysis","volume":"50","author":"Bradburn","year":"2019","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.neurol.2022.12.006_bib2170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neurobiolaging.2016.04.011","article-title":"11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease","volume":"44","author":"Kreisl","year":"2016","journal-title":"Neurobiology of Aging"},{"issue":"5","key":"10.1016\/j.neurol.2022.12.006_bib2175","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/brain\/awaa088","article-title":"Microglial activation and tau burden predict cognitive decline in Alzheimer's disease","volume":"143","author":"Malpetti","year":"2020","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib2180","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awx120","article-title":"Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease","volume":"140","author":"Parbo","year":"2017","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib2185","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib2190","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib2195","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3597","article-title":"Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers","volume":"1","author":"Tao","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib2200","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbi.2011.07.240","article-title":"C-reactive protein is related to memory and medial temporal brain volume in older adults","volume":"26","author":"Bettcher","year":"2012","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurol.2022.12.006_bib2205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnagi.2019.00025","article-title":"Increases in a pro-inflammatory Chemokine, MCP-1, are related to decreases in memory over time","volume":"11","author":"Bettcher","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neurol.2022.12.006_bib2210","article-title":"Plasma IL-12\/IFN-\u03b3 axis predicts cognitive trajectories in cognitively unimpaired older adults","author":"Yang","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib2215","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11481-015-9612-2","article-title":"T Cells-Protective or Pathogenic in Alzheimer's Disease?","volume":"10","author":"McManus","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"issue":"Pt 9","key":"10.1016\/j.neurol.2022.12.006_bib2220","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awt210","article-title":"Inflammatory components in human Alzheimer's disease and after active amyloid-\u03b242 immunization","volume":"136","author":"Zotova","year":"2013","journal-title":"Brain"},{"issue":"7790","key":"10.1016\/j.neurol.2022.12.006_bib2225","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","article-title":"Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease","volume":"577","author":"Gate","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib2230","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(20)30076-4","article-title":"T cells in Alzheimer's disease: space invaders","volume":"19","author":"McManus","year":"2020","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib2235","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3233\/JAD-130914","article-title":"Posttranslational nitro-glycative modifications of albumin in Alzheimer's disease: implications in cytotoxicity and amyloid-\u03b2 peptide aggregation","volume":"40","author":"Ramos-Fern\u00e1ndez","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib2240","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3233\/JAD-180243","article-title":"Increased albumin oxidation in cerebrospinal fluid and plasma from Alzheimer's disease patients","volume":"63","author":"Costa","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib2245","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/alz.12137","article-title":"A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study","volume":"16","author":"Boada","year":"2020","journal-title":"Alzheimer's Dementia"},{"issue":"12","key":"10.1016\/j.neurol.2022.12.006_bib2250","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41583-020-00381-0","article-title":"Gut microbial molecules in behavioural and neurodegenerative conditions","volume":"21","author":"Needham","year":"2020","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib2255","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat Neurosci"},{"issue":"8","key":"10.1016\/j.neurol.2022.12.006_bib2260","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/jcp.25742","article-title":"TUDCA: An Agonist of the Bile Acid Receptor GPBAR1\/TGR5 With Anti-Inflammatory Effects in Microglial Cells","volume":"232","author":"Yanguas-Cas\u00e1s","year":"2017","journal-title":"J Cell Physiol"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib2265","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.4106","article-title":"Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor","volume":"22","author":"Rothhammer","year":"2016","journal-title":"Nat Med"},{"issue":"7707","key":"10.1016\/j.neurol.2022.12.006_bib2270","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41586-018-0119-x","article-title":"Microglial control of astrocytes in response to microbial metabolites","volume":"557","author":"Rothhammer","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2022.12.006_bib2275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","article-title":"Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly","volume":"49","author":"Cattaneo","year":"2017","journal-title":"Neurobiol Aging"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib2280","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/apt.12453","article-title":"Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study","volume":"38","author":"Macfarlane","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.neurol.2022.12.006_bib2285","doi-asserted-by":"crossref","first-page":"102950","DOI":"10.1016\/j.ebiom.2020.102950","article-title":"Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: a pilot study","volume":"59","author":"Nagpal","year":"2020","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib2290","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s42255-021-00348-0","article-title":"Gut microbiome pattern reflects healthy ageing and predicts survival in humans","volume":"3","author":"Wilmanski","year":"2021","journal-title":"Nat Metab"},{"issue":"10","key":"10.1016\/j.neurol.2022.12.006_bib2295","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib2300","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13195-020-00678-3","article-title":"A phase II randomized trial of sodium oligomannate in Alzheimer's dementia","volume":"12","author":"Wang","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib2305","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13195-021-00795-7","article-title":"A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia","volume":"13","author":"Xiao","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib2310","doi-asserted-by":"crossref","first-page":"e12179","DOI":"10.1002\/trc2.12179","article-title":"Alzheimer's disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.neurol.2022.12.006_bib2315","doi-asserted-by":"crossref","first-page":"101339","DOI":"10.1016\/j.arr.2021.101339","article-title":"Effects of monoclonal antibodies against amyloid-\u03b2 on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer's disease","volume":"68","author":"Avgerinos","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib2320","doi-asserted-by":"crossref","first-page":"E53","DOI":"10.25011\/cim.v42i1.32393","article-title":"Safety and efficacy of active and passive immunotherapy in mild-to-moderate Alzheimer's disease: A systematic review and network meta-analysis","volume":"42","author":"Foroutan","year":"2019","journal-title":"Clin Invest Med"},{"issue":"12","key":"10.1016\/j.neurol.2022.12.006_bib2325","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/acn3.469","article-title":"Efficacy and safety of anti-amyloid-\u03b2 immunotherapy for Alzheimer's disease: a systematic review and network meta-analysis","volume":"4","author":"Mo","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib2330","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11481-016-9722-5","article-title":"Safety and efficacy of Anti-Amyloid-\u03b2 Immunotherapy in Alzheimer's Disease: a systematic review and meta-analysis","volume":"12","author":"Penninkilampi","year":"2017","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.neurol.2022.12.006_bib2335","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in Early Alzheimer's Disease","author":"Budd\u00a0Haeberlein","year":"2022","journal-title":"J Prev Alz Dis"},{"issue":"18","key":"10.1016\/j.neurol.2022.12.006_bib2340","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in Early Alzheimer's Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib2345","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-A\u03b2 protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib2350","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41591-021-01369-8","article-title":"A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease","volume":"27","author":"Salloway","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib2355","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41591-021-01434-2","article-title":"Dominantly inherited Alzheimer's disease: a compass for drug development","volume":"27","author":"Rabinovici","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib2360","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2022.12.006_bib2365","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fimmu.2020.00456","article-title":"A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's Disease","volume":"11","author":"Hampel","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib2370","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3233\/JAD-210236","article-title":"Taking the A train? Limited Consistency of A\u03b242 and the A\u03b242\/40 Ratio in the AT(N) Classification","volume":"83","author":"Gouilly","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"10.1016\/j.neurol.2022.12.006_bib2375","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"The Lancet Neurology"},{"issue":"6","key":"10.1016\/j.neurol.2022.12.006_bib2380","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neuron.2022.01.017","article-title":"The different autophagy degradation pathways and neurodegeneration","volume":"110","author":"Fleming","year":"2022","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib2385","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","article-title":"The gut microbiome in neurological disorders","volume":"19","author":"Cryan","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2022.12.006_bib2390","article-title":"The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis","author":"Ashleigh","year":"2022","journal-title":"Alzheimer's Dementia"},{"issue":"8","key":"10.1016\/j.neurol.2022.12.006_bib2395","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease \u2014 the gateway to precision medicine","volume":"14","author":"for the Women's Brain Project and the Alzheimer Precision Medicine Initiative et al.","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib2400","first-page":"e12295","volume":"8","author":"Cummings","year":"2022","journal-title":"Alzheimer's disease drug development pipeline: 2022. Alzheimers Dement (N Y)"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib2405","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3233\/JAD-215707","article-title":"Precision Medicine Approach to Alzheimer's Disease: successful pilot project","volume":"88","author":"Toups","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"10.1016\/j.neurol.2022.12.006_bib2410","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/alz.12123","article-title":"World-Wide FINGERS Network: a global approach to risk reduction and prevention of dementia","volume":"16","author":"Kivipelto","year":"2020","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neurol.2022.12.006_bib2415","first-page":"1","article-title":"Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: from FINGER to World-Wide FINGERS","author":"Rosenberg","year":"2019","journal-title":"J Prev Alz Dis"},{"issue":"2","key":"10.1016\/j.neurol.2022.12.006_bib2420","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3233\/JAD-2009-1151","article-title":"Reexamining Alzheimer's Disease: evidence for a protective role for Amyloid-\u03b2 Protein Precursor and Amyloid-\u03b2","volume":"18","author":"Castellani","year":"2009","journal-title":"JAD"},{"issue":"1","key":"10.1016\/j.neurol.2022.12.006_bib2425","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2018.06.030","article-title":"Alzheimer's Disease-Associated \u03b2-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection","volume":"99","author":"Eimer","year":"2018","journal-title":"Neuron"},{"issue":"340","key":"10.1016\/j.neurol.2022.12.006_bib2430","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1059","article-title":"Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer's disease","volume":"8","author":"Kumar","year":"2016","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.neurol.2022.12.006_bib2435","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","article-title":"The antimicrobial protection hypothesis of Alzheimer's disease","volume":"14","author":"Moir","year":"2018","journal-title":"Alzheimer's Dementia"},{"issue":"3","key":"10.1016\/j.neurol.2022.12.006_bib2440","doi-asserted-by":"crossref","first-page":"e9505","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer's Disease-Associated Amyloid \u03b2-Protein Is an Antimicrobial Peptide","volume":"5","author":"Soscia","year":"2010","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.neurol.2022.12.006_bib2445","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41582-020-0323-9","article-title":"Do infections have a role in the pathogenesis of Alzheimer disease?","volume":"16","author":"Itzhaki","year":"2020","journal-title":"Nat Rev Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723008706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723008706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:46:52Z","timestamp":1758520012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378723008706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":290,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0035378723008706"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2022.12.006","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2022.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}